Six Hunter researchers and their projects have received a combined total of $10.6 million in the latest round of grants from the National Health and Medical Research Council.
The three NHMRC Investigator Grants and three Medical Research Future Fund (MRFF) Investigator Grants will be led by affiliates with the University of Newcastle, the Hunter Medical Research Institute, and Hunter New England Health, and will address critical areas of concern in chronic disease prevention and community health outcomes
Associate Professor Luke Wolfenden will receive more than $2.7 million over five years to examine methods of promoting positive health behaviours such as physical activity, a healthy diet and qutting smoking.
Professor Frances Kay-Lambkin will receive more than $2 million over five years to examine mental health treatment and potential usage of technology in improving access.
Associate Professor Kelvin Kong will receive more than $1 million to study a telehealth ear, nose and throat (ENT) model in the context of metropolitan, rural and regional Aboriginal Community Controlled Health Services, focusing on improvement in Aboriginal children’s access to specialist care and a reduction in waiting times for treatment.
Dr Rachel Sutherland and Dr Nicole Nathan were each awarded $1.5 million to examine the effectiveness of chronic disease prevention programs within communities and schools.
Dr Vanessa Murphy was also awarded $1.5 million to fund research into asthma care during pregnancy and the implementation of this research into local, national, and international clinical practice.
University of Newcastle Deputy Vice-Chancellor (Research & Innovation), Professor Janet Nelson, said the funding success was recognition of the vital research being conducted across the Hunter Region.
“As we navigate a very challenging funding environment, it is incredibly encouraging to see our researchers continue to be recognised for their important work," Professor Nelson said. "While globally, there is a united focus on combatting COVID-19, it is essential that we continue to strive and invest in understanding and developing novel treatments for the vast array of health concerns that continue to affect our populations."
“I sincerely congratulate all our recipients of today’s announcement and I look forward to seeing the results of their impactful projects.”
Find out more about the research here.
